COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 526: Articles 5251-5260  | Next

Omicron Spike Protein Is Vulnerable to Reduction
Stagljar, I., Yao, Z., Geng, B., Marcon, E., Pu, S., Tang, H., Merluza, J., Bello, A., Snider, J., Lu, P., Wood, H.
10.1101/2023.01.06.522977 — Posted: 2023-01-06
Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides
Llewellyn, G. N., Chen, H.-Y., Rogers, G. L., Huang, X., Sell, P., Henley, J. E., Cannon, P. M.
10.1101/2023.01.05.522964 — Posted: 2023-01-06
Direct comparison of clinical diagnostic sensitivity of saliva from buccal swabs versus combined oro-/nasopharyngeal swabs in the detection of SARS-CoV-2 B.1.1.529 Omicron
Puyskens, A., Michel, J., Stoliaroff-Pepin, A., Bayram, F., Sesver, A., Wichmann, O., Harder, T., Schaade, L., Nitsche, A., Peine, C.
10.1101/2023.01.05.23284222 — Posted: 2023-01-06
Clinical Characteristics and Outcomes of Laboratory-Confirmed SARS-CoV-2 Cases Infected with Omicron subvariants and XBB recombinant variant
Karyakarte, R., Das, R., Dudhate, S., Agarasen, J., Pillai, P., Chandankhede, P., Labhshetwar, R., Gadiyal, Y., Rajmane, M., Kulkarni, P., Nizarudeen, S., Joshi, S., Potdar, V., Karmodiya, K.
10.1101/2023.01.05.23284211 — Posted: 2023-01-06
Cost & Cost-Effectiveness of Implementing SD Biosensor Antigen Detecting SARs-CoV-2 Rapid Diagnostic Tests in Kenya
Arwah, B., Mbugua, S., Ngure, J., Makau, M., Mwaura, P., Kamau, D., Nshimirimana, D. A., Barasa, E., Gitaka, J.
10.1101/2023.01.05.23284225 — Posted: 2023-01-05
Ethnic differences in the indirect impacts of the COVID-19 pandemic on clinical monitoring and hospitalisations for non-COVID conditions in England: An observational cohort study using OpenSAFELY
Costello, R. E., Tazare, J., Piehlmaier, D., Herrett, E., Parker, E. P., Zheng, B., Mansfield, K. E., Henderson, A. D., Carreira, H., Bidulka, P., Wong, A. Y., Warren-Gash, C., Hayes, J. F., Quint, J. K., MacKenna, B., Eggo, R. M., Katikireddi, S. V., Tomlinson, L., Langan, S. M., Mathur, R., The longitudinal health and wellbeing, , The OpenSAFELYcollaborative
10.1101/2023.01.04.23284174 — Posted: 2023-01-05
SARS-CoV-2 Reinfection is Preceded by Unique Biomarkers and Related to Initial Infection Timing and Severity: an N3C RECOVER EHR-Based Cohort Study
Hadley, E. C., Yoo, Y. J., Patel, S. V., Zhou, A. G., Laraway, B., Wong, R., Preiss, A. J., Chew, R., Davis, H., Chute, C. G., Pfaff, E., Loomba, J. J., Haendel, M., Hill, E. L., Moffitt, R. A., the N3C and RECOVER Consortia
10.1101/2023.01.03.22284042 — Posted: 2023-01-05
The SARS-CoV-2 Spike protein induces long-term transcriptional perturbations of mitochondrial metabolic genes, causes cardiac fibrosis, and reduces myocardial contractile in obese mice
Cao, X., Nguyen, V., Tsai, J., Gao, C., Tian, Y., Zhang, Y., Carver, W., Kiaris, H., Cui, T., Tan, W.
10.1101/2023.01.05.522853 — Posted: 2023-01-05
Poor neutralizing antibody responses against SARS-CoV-2 Omicron BQ.1.1 and XBB in Norway in October 2022
Vikse, E. L., Fossum, E., Erdal, M. S., Hungnes, O., Bragstad, K.
10.1101/2023.01.05.522845 — Posted: 2023-01-05
Targets and cross-reactivity of human T cell recognition of Common Cold Coronaviruses
Tarke, A., Zhang, Y., Methot, N., Narowski, T. N., Phillips, E., Mallal, S., Frazier, A., Filaci, G., Weiskopf, D., Dan, J. M., Lakshmanane, P., Scheuermann, R. H., Sette, A., Grifoni, A.
10.1101/2023.01.04.522794 — Posted: 2023-01-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).